13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)
Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Management......(read more)
Posts Tagged ‘NASDAQ:CYCC’
Why Cyclacel Pharmaceuticals Inc (CYCC) is in the Spotlight
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares have popped over 30% this afternoon due to momentum traders buying the stock for technical reasons.......(read more)
Here’s What Is Happening In Financial Markets Today?
1. US Stock Market: “Wall Street stocks on Monday were aiming to start the second quarter with tepid gains. Investors were set to take cues from a handful......(read more)
Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)
This week was a good one for a few biotechs, but not so great for others. Two in particular have just put out news relating to trials for their lead investigative......(read more)
Here’s Why Cyclacel Pharmaceuticals Inc (CYCC) Could Have A Rough December
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) soared throughout the US session on Thursday, gaining as much as 60% across the day. The company dipped into......(read more)
Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI)
Yet again, we’ve had a busy start to the week in biotech. A number of companies are moving on news or data reported at the close of last week, and others......(read more)
Why Are Traders Piling Into These Stocks?
Crude futures are up more than 2% this morning as weakness in the dollar and supply disturbances boost sentiment. Not surprisingly, all three major indexes......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action......(read more)
Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)
Kevin C. Tang‘s Tang Capital Management has decreased its position it two pharmaceutical companies. The $200 million hedge fund recently decreased......(read more)
Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot
Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed......(read more)
Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)
Is Affymax, Inc. (NASDAQ:AFFY) the right pick for your portfolio? Hedge funds are becoming less confident. The number of bullish hedge fund bets dropped......(read more)
